Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Guidelines for Therapeutic Drug Monitoring of Cardiovascular Drugs Clinical Use of Blood Drug Concentration Monitoring (JCS 2015) - Digest Version.

Aonuma K, Shiga T, Atarashi H, Doki K, Echizen H, Hagiwara N, Hasegawa J, Hayashi H, Hirao K, Ichida F, Ikeda T, Maeda Y, Matsumoto N, Sakaeda T, Shimizu W, Sugawara M, Totsuka K, Tsuchishita Y, Ueno K, Watanabe E, Hashiguchi M, Hirata S, Kasai H, Matsumoto Y, Nogami A, Sekiguchi Y, Shinohara T, Sugiyama A, Sumitomo N, Suzuki A, Takahashi N, Yukawa E, Homma M, Horie M, Inoue H, Ito H, Miura T, Ohe T, Shinozaki K, Tanaka K; Japanese Circulation Society and the Japanese Society of Therapeutic Drug Monitoring Joint Working Group.

Circ J. 2017 Mar 24;81(4):581-612. doi: 10.1253/circj.CJ-66-0138. Epub 2017 Mar 9. No abstract available.

2.

[Therapeutic drug monitoring: clinical practice].

Widmer N, Werner D, Grouzmann E, Eap CB, Marchetti O, Fayet A, Csajka C, Decosterd LA, Buclin T.

Rev Med Suisse. 2008 Jul 16;4(165):1649-50, 1652-60. French.

PMID:
18767291
3.

[Principles of therapeutic drug monitoring].

Widmer N, Csajka C, Werner D, Grouzmann E, Decosterd LA, Eap CB, Biollaz J, Buclin T.

Rev Med Suisse. 2008 Jul 16;4(165):1644-8. Review. French.

PMID:
18767290
4.

Titrating cardiovascular drugs.

Marcus FI.

Clin Chem. 1996 Aug;42(8 Pt 2):1312-5. Review.

5.

An LC-MS assay for the screening of cardiovascular medications in human samples.

Dias E, Hachey B, McNaughton C, Nian H, Yu C, Straka B, Brown NJ, Caprioli RM.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 15;937:44-53. doi: 10.1016/j.jchromb.2013.08.010. Epub 2013 Aug 16.

6.

Baseline and follow-up laboratory monitoring of cardiovascular medications.

Tjia J, Fischer SH, Raebel MA, Peterson D, Zhao Y, Gagne SJ, Gurwitz JH, Field TS.

Ann Pharmacother. 2011 Sep;45(9):1077-84. doi: 10.1345/aph.1Q158. Epub 2011 Aug 18.

PMID:
21852593
7.

Clinical applications of fast liquid chromatography: a review on the analysis of cardiovascular drugs and their metabolites.

Baranowska I, Magiera S, Baranowski J.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 May 15;927:54-79. doi: 10.1016/j.jchromb.2013.02.002. Epub 2013 Feb 8. Review.

PMID:
23462623
8.

Development of an LC-MS/MS method for the quantitation of 55 compounds prescribed in combined cardiovascular therapy.

Gonzalez O, Alonso RM, Ferreirós N, Weinmann W, Zimmermann R, Dresen S.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Feb 1;879(3-4):243-52. doi: 10.1016/j.jchromb.2010.12.007. Epub 2010 Dec 15.

PMID:
21190906
9.
10.

Effect of blood protein concentrations on drug-dosing regimes: practical guidance.

Gurevich KG.

Theor Biol Med Model. 2013 Mar 18;10:20. doi: 10.1186/1742-4682-10-20.

11.

Therapeutic drug monitoring: observations and recommendations.

Murphy JE.

Am J Health Syst Pharm. 1998 Jun 15;55(12):1306-7. No abstract available.

PMID:
9640474
12.

Therapeutic drug monitoring in cardiology: recognizing pitfalls and problems.

Ochs HR, Greenblatt DJ.

Am Heart J. 1987 Jul;114(1 Pt 1):204-8. No abstract available.

PMID:
3604870
13.

Fast, simultaneous quantification of three novel cardiac drugs in human urine by MEPS-UHPLC-MS/MS for therapeutic drug monitoring.

Magiera S.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Nov 1;938:86-95. doi: 10.1016/j.jchromb.2013.09.001. Epub 2013 Sep 8.

PMID:
24076522
14.

Adverse events monitoring as a routine component of vaccine clinical trials: evidence from the WHO Vaccine Trial Registry.

Mayans MV, Robertson SE, Duclos P.

Bull World Health Organ. 2000;78(9):1167. No abstract available.

15.

Australian cyclosporin therapeutic monitoring method survey: 1993.

Morris RG.

Ther Drug Monit. 1994 Dec;16(6):564-9.

PMID:
7878695
16.

Cardiovascular drugs: reason for promise and vigilance.

Miller CA.

Geriatr Nurs. 2002 May-Jun;23(3):171-2. No abstract available.

PMID:
12075284
17.

Guidelines for the clinical use of 24 hour ambulatory blood pressure monitoring (ABPM) (JCS 2010): – digest version –.

JCS Joint Working Group.

Circ J. 2012;76(2):508-19. Epub 2012 Jan 7. No abstract available.

18.

Clinical practice algorithms: medication management to reduce fall risk in the elderly--Part 3, benzodiazepines, cardiovascular agents, and antidepressants.

Bulat T, Castle SC, Rutledge M, Quigley P.

J Am Acad Nurse Pract. 2008 Feb;20(2):55-62. doi: 10.1111/j.1745-7599.2007.00285.x. Review. No abstract available.

PMID:
18271759
19.

[Serum concentration measurement of cardiovascular drugs: why, when and how?].

Follath F.

Ther Umsch. 1982 Feb;39(2):103-8. German. No abstract available.

PMID:
7071782
20.

Automated capillary electrophoresis applied to therapeutic drug monitoring.

Evenson MA, Wiktorowicz JE.

Clin Chem. 1992 Sep;38(9):1847-52.

Supplemental Content

Support Center